Andreessen Horowitz July 22, 2020
Vijay Pande and Andy Tran

For generations, the field of biology has been largely defined by its discoveries. Now, because many crucial aspects of biology have begun the transition from an empirical science to an engineering discipline, the pendulum is shifting from “What can we discover?” to “What can we solve?”. Nowhere is this perhaps more evident than in the global scientific community’s collective response to combat a global pandemic—pushing us even further into one of the most prolific periods in the world of bio in both scientific and commercial development we have ever seen.

As our engineering toolkit in bio expands to be more powerful than ever before, and the infrastructure to deliver, produce, and scale these solutions comes increasingly online, a whole new...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Precision Medicine
Covid’s scientific silver lining: A chance to watch the human immune system respond in real time
How GLP-1’s moved from research labs to national TV
Understanding the politics of drug pricing in the United States
Opinion: Oprah kicked off a national conversation on obesity and GLP-1 drugs. Let’s have it
Brazil’s plan for low-cost CAR-Ts

Share This Article